Sensus Healthcare, Inc. (SRTS) Stock Sinks As Market Gains: Here's Why
We Like These Underlying Return On Capital Trends At Sensus Healthcare (NASDAQ:SRTS)
Sensus Healthcare, Inc. (SRTS) Stock Declines While Market Improves: Some Information for Investors
Sensus Healthcare, Inc. (SRTS) Stock Slides as Market Rises: Facts to Know Before You Trade
What Is Sensus Healthcare, Inc.'s (NASDAQ:SRTS) Share Price Doing?
Here's Why Momentum in Sensus Healthcare (SRTS) Should Keep Going
Sensus Healthcare Announces Board Member Resignation
Are Medical Stocks Lagging Sensus Healthcare (SRTS) This Year?
Sensus Healthcare(SRTS.US) Director Sells US$123.42K in Common Stock
$Sensus Healthcare(SRTS.US)$ Director Heinrich John sold 20,000 shares of common stock on May 17, 20, 2024 at an average price of $6.17 for a total value of $123.42K.Source: Announcement What is state
Sensus Healthcare Is Maintained at Buy by HC Wainwright & Co.
Sensus Healthcare Is Maintained at Buy by HC Wainwright & Co.
HC Wainwright & Co. Maintains Buy on Sensus Healthcare, Raises Price Target to $10
HC Wainwright & Co. analyst Yi Chen maintains Sensus Healthcare (NASDAQ:SRTS) with a Buy and raises the price target from $8 to $10.
Is Sensus Healthcare, Inc.'s (NASDAQ:SRTS) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
NVAX, GRPN and MVIS Among Mid-day Movers
Sensus Healthcare | 10-Q: Quarterly report
Sensus Healthcare Is Maintained at Buy by Maxim Group
Sensus Healthcare Is Maintained at Buy by Maxim Group
Maxim Group: Maintains Sensus Healthcare (SRTS.US) rating, adjusted from buy to buy rating, and adjusted target price from $7.00 to $10.00.
Maxim Group: Maintains Sensus Healthcare (SRTS.US) rating, adjusted from buy to buy rating, and adjusted target price from $7.00 to $10.00.
Maxim Group Maintains Buy on Sensus Healthcare, Raises Price Target to $10
Maxim Group analyst Anthony Vendetti maintains Sensus Healthcare (NASDAQ:SRTS) with a Buy and raises the price target from $7 to $10.
Sensus Healthcare Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/10/2024 115.99% Maxim Group $7 → $10 Maintains Buy 11/13/2023 72.79% HC Wainwright & Co. → $8 Reiterate
Novavax, Macrogenics, Biofrontera Among Healthcare Movers
Sensus Healthcare Shares Are Trading Higher After Following the Company's Better-than-expected Q1 Financial Results.
Sensus Healthcare Shares Are Trading Higher After Following the Company's Better-than-expected Q1 Financial Results.